Latest filing published 05 May 2023 for Catalyst Pharmaceuticals, INC., €36k. Read the official filing
This profile gathers the share dealings of Philip H. Coelho across 2 companies, led by Catalyst Pharmaceuticals, Inc. and Ampio Pharmaceuticals, Inc. In total, 10 filings cover trades dated from 4 January 2016 to 4 May 2023.
The open-market record consists of 2 sales worth €1.2M, with no purchase. The rest of the record consists of 1 share grant and 7 option exercises.
The newest entry dates from 5 May 2023: an option exercise of €36k, in Catalyst Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations